VGF as a biomarker and therapeutic target in neurodegenerative and psychiatric diseases
James P. Quinn, Savannah E. Kandigian, Bianca A. Trombetta, Steven Edward Arnold, Becky Catherine Carlyle
Journal
- ISSN / E-ISSN
- — / —
- DOI
- 10.1093/braincomms/fcab261 ↗
- Volume · Issue · Pages
- 3 · 4 · fcab261-fcab261
- Publisher
- Oxford University Press
- Article URL
- https://doi.org/10.1093/braincomms/fcab261 ↗
- Article details
- Unverified
Publication date (each date has its type and source)
01 Oct 2021
OpenAlex publication date · source: OpenAlex
| Type | Date | Source |
|---|---|---|
| OpenAlex publication date | 01 Oct 2021 | OpenAlex |
Keywords (as given): VGF; neuropeptides; Alzheimer's disease; TLQP-21; biomarkers; therapeutic target; neurodegenerative diseases; mental illness; microglia; amyloid plaques; depression; frontotemporal lobar degeneration; amyotrophic lateral sclerosis; Lewy body disease; Huntington's disease; schizophrenia
HEC Status at Publication Not the journal's current status
HEC Status at PublicationConclusive
HEC status at publication
Recognized
Y
Based on the recorded HEC dataset applicable to the article's publication date. Listed as Y in the HEC list for hjrs 2021-22 V2.
- Journal
- Brain Communications
- Publication date used
- 01 Oct 2021 (OpenAlex publication date)
- Applicable HEC period
- hjrs 2021-22 V2 (version 1) · 01 Jul 2021 – 30 Jun 2022
- Category
- Y
- Recognition status
- Recognized (OK_RECORD_FOUND)
- Source
- hjrs-2021-22 row 44318
- Verification status
- Verified against source · last verified 16 Oct 2026
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.